Latest Insider Transactions at Actinium Pharmaceuticals, Inc. (ATNM)
This section provides a real-time view of insider transactions for Actinium Pharmaceuticals, Inc. (ATNM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Actinium Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Actinium Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 18
2025
|
Sandesh Seth Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
120,900
-39.59%
|
$120,900
$1.71 P/Share
|
|
Aug 17
2022
|
Sandesh Seth Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+49.56%
|
-
|